Search

Rachel Boothroyd was working as a successful lawyer in the city when she felt something was wrong with her body. "I thought heart disease was a risk I could manage – I don’t drink, I don’t smoke, and I watch what I eat. I thought I could stay on top of it, but heart disease came into my life as it does for so many people. It’s one of the biggest killers in the UK."

Working with other charities in Scotland, we’re calling for all political parties to commit to take the actions that could save thousands of lives from preventable diseases.

People  with heart and circulatory diseases can contribute to the fight against the coronavirus (Covid-19) by downloading a symptoms-logging app developed by leading researchers.

The weight loss medication semaglutide – better known as Wegovy – can benefit people living with heart failure and obesity, according to research presented today at the European Society of Cardiology (ESC) Congress in Amsterdam and published in the New England Journal of Medicine.

We fund research into many heart and circulatory diseases across the UK. Explore where we are funding lifesaving research and clinical trials through our interactive visualisations.

A doctor has questioned the use of the cholesterol-lowering drug rosuvastatin (Crestor).

$name

The statistics in our publications are drawn from a wide variety of official and reputable sources.

New research we part-funded has revealed that having a low birthweight increases the risk of developing heart disease, independently of the intrauterine environment.

We have awarded funding to Belfast scientist Dr Karla O'Neill for research that will help to bring us a step closer to creating treatments that can restore the body’s ability to grow new blood vessels